Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

OMER Aug 2022 9.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.10000.0000 (0.00%)
As of 09:30AM EDT. Market open.
Advertisement
Full screen
Previous Close0.1000
Open0.1000
Bid0.1000
Ask0.1500
Strike9.00
Expire Date2022-08-19
Day's Range0.1000 - 0.1000
Contract RangeN/A
Volume10
Open Interest127
  • Business Wire

    Omeros Announces Webcast Details for Annual Meeting of Shareholders

    SEATTLE, June 15, 2022--Omeros Corporation (Nasdaq: OMER), today announced that the company will host a live webcast of its Annual Meeting of Shareholders, which will be held virtually, on Friday, June 17, 2022, starting at 10:00 a.m. Pacific Time.

  • Business Wire

    Omeros Corporation Reports First Quarter 2022 Financial Results

    SEATTLE, May 10, 2022--Omeros Corporation (Nasdaq: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation and immunologic diseases, including complement-mediated diseases and cancers, today announced recent highlights and developments as well as financial results for the first quarter ended March 31, 2022, which include:

  • Business Wire

    Omeros Corporation to Announce First Quarter Financial Results on May 10, 2022

    SEATTLE, May 04, 2022--Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its first quarter financial results for the period ended March 31, 2022, on Tuesday, May 10, 2022, after the market closes. Omeros management will host a conference call and webcast that day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results as well as recent developments and highlights.

Advertisement
Advertisement